June 22, 2023 – Sarepta Therapeutics, Inc., announced U.S. Food and Drug Administration (FDA)
accelerated approval of Elevidys (delandistrogene moxeparvovec-rokl)
June 20, 2023 - AGEPHA Pharma USA, LLC, has announced that, following a Priority Review, the U.S. Food and Drug Administration (FDA) has approved Lodoco®